Category Archives: News and Events

BriaCell Announces Grant to Investigator Dr. Saveri Bhattacharya at Sidney Kimmel Cancer Center – Jefferson Health for Phase I/IIa Combination Study of Bria-IMT™

· Grant awarded to Dr. Saveri Bhattacharya, Principal Investigator of the Phase I/IIa combination study ...

BriaCell’s Clinical Data Accepted to be Presented at the Annual Symposium of Society of Surgical Oncology 2020 in Boston

Safety and early efficacy data to be presented from clinical trial of Bria-IMT™ in combination ...

BriaCell Invited to Present at Mount Sinai’s Frontiers in Academic Pathology Symposium at The New York Academy of Medicine

BERKELEY, Calif., and VANCOUVER, British Columbia, January 22, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Provides Update on Remarkable Responder

• Patient initially identified September 19, 2019 as a Remarkable Responder; • Patient has continued ...

BriaCell Outlines New High Responding Patient Group ‘Biomarker’ Based on Cancer Grade

• BriaCell has identified a patient population Biomarker with high rate of clinical benefit from ...

BriaCell Completes Share Consolidation

BERKELEY, Calif., and VANCOUVER, British Columbia, January 2, 2020 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Therapeutics Corp. Announces Share Consolidation

BERKELEY, Calif., and VANCOUVER, British Columbia, December 24, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell to Present at Biotech Showcase™ 2020 in San Francisco

BERKELEY, Calif., and VANCOUVER, British Columbia, December 17, 2019 — BriaCell Therapeutics Corp. (“BriaCell” or ...

BriaCell Announces Clinical Data as Presented at the 2019 San Antonio Breast Cancer Symposium®

Safety and early efficacy data were presented on December 12th at 6:00 p.m. ET from ...

BriaCell to Present Clinical Findings at the 2019 San Antonio Breast Cancer Symposium® December 12th and 13th

Safety and early efficacy data to be presented from clinical trial of Bria-IMT™ in combination ...